Guizhou Xinbang Pharmaceutical Co Ltd
Guizhou Xinbang Pharmaceutical Co., Ltd. manufactures and sells traditional Chinese medicine and other pharmaceutical products in China and internationally. The company cardiovascular and cerebrovascular, digestive system, endocrine, tumors and immunomodulatory drugs, blood system drugs, rheumatism and rheumatoid arthritis, urinary system, antipyretic and analgesic, cold medicine, gynecological m… Read more
Guizhou Xinbang Pharmaceutical Co Ltd (002390) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.034x
Based on the latest financial reports, Guizhou Xinbang Pharmaceutical Co Ltd (002390) has a cash flow conversion efficiency ratio of 0.034x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥234.19 Million) by net assets (CN¥6.97 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Guizhou Xinbang Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2006–2024)
This chart illustrates how Guizhou Xinbang Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Guizhou Xinbang Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Guizhou Xinbang Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Guizhou Qianyuan Power Co Ltd
SHE:002039
|
0.125x |
|
ZWSOFT Guangzhou Co Ltd
SHG:688083
|
0.046x |
|
Daily Journal Corp
NASDAQ:DJCO
|
-0.005x |
|
Jiangsu Chengxing Phosph-Chemical Co Ltd
SHG:600078
|
0.150x |
|
Pantoro Gold Ltd
AU:PNR
|
0.247x |
|
Guangxi Liuzhou Pharm Co Ltd
SHG:603368
|
0.006x |
|
ROMANDE ENERGIE SA
SW:REHN
|
0.025x |
|
Nanjing Develop Advanced Manufacturing Co Ltd
SHG:688377
|
0.049x |
Annual Cash Flow Conversion Efficiency for Guizhou Xinbang Pharmaceutical Co Ltd (2006–2024)
The table below shows the annual cash flow conversion efficiency of Guizhou Xinbang Pharmaceutical Co Ltd from 2006 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥7.02 Billion | CN¥634.97 Million | 0.090x | -18.29% |
| 2023-12-31 | CN¥7.14 Billion | CN¥790.62 Million | 0.111x | +32.38% |
| 2022-12-31 | CN¥7.07 Billion | CN¥590.80 Million | 0.084x | +24.68% |
| 2021-12-31 | CN¥6.83 Billion | CN¥457.97 Million | 0.067x | -53.29% |
| 2020-12-31 | CN¥5.17 Billion | CN¥742.11 Million | 0.144x | -18.22% |
| 2019-12-31 | CN¥5.05 Billion | CN¥886.33 Million | 0.176x | +515.18% |
| 2018-12-31 | CN¥5.17 Billion | CN¥-218.56 Million | -0.042x | -241.67% |
| 2017-12-31 | CN¥6.76 Billion | CN¥201.74 Million | 0.030x | +197.48% |
| 2016-12-31 | CN¥6.49 Billion | CN¥-198.59 Million | -0.031x | -137.59% |
| 2015-12-31 | CN¥2.67 Billion | CN¥217.40 Million | 0.081x | +200.81% |
| 2014-12-31 | CN¥2.46 Billion | CN¥-198.60 Million | -0.081x | -292.27% |
| 2013-12-31 | CN¥1.04 Billion | CN¥-21.34 Million | -0.021x | +42.23% |
| 2012-12-31 | CN¥1.02 Billion | CN¥-36.46 Million | -0.036x | +12.39% |
| 2011-12-31 | CN¥979.53 Million | CN¥-39.87 Million | -0.041x | -1661.76% |
| 2010-12-31 | CN¥959.70 Million | CN¥2.50 Million | 0.003x | -98.42% |
| 2009-12-31 | CN¥252.83 Million | CN¥41.75 Million | 0.165x | +37.96% |
| 2008-12-31 | CN¥207.69 Million | CN¥24.86 Million | 0.120x | -35.86% |
| 2007-12-31 | CN¥174.08 Million | CN¥32.49 Million | 0.187x | +266.24% |
| 2006-12-31 | CN¥144.17 Million | CN¥7.35 Million | 0.051x | -- |